{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:04:42Z","timestamp":1761919482386},"reference-count":58,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.ncl.2011.05.001","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T00:39:39Z","timestamp":1310171979000},"page":"657-665","source":"Crossref","is-referenced-by-count":10,"title":["Trichloroethylene and Parkinson Disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Fariha","family":"Zaheer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Slevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ncl.2011.05.001_bib1","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.neuro.2010.04.007","article-title":"Gene\u2013environment interactions in Parkinson\u2019s disease and other forms of parkinsonism","volume":"31","author":"Vance","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ncl.2011.05.001_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-006-9061-9","article-title":"Cellular and molecular mechanisms of Parkinson\u2019s disease: neurotoxins, causative genes, and inflammatory cytokines","volume":"26","author":"Nagatsu","year":"2006","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.ncl.2011.05.001_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1531-8257(199901)14:1<28::AID-MDS1007>3.0.CO;2-O","article-title":"Nutritional and occupational factors influencing the risk of Parkinson\u2019s disease: a case\u2013control study in southeastern Sweden","volume":"14","author":"Fall","year":"1999","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2011.05.001_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1212\/WNL.48.3.650","article-title":"Occupational exposures to metals as risk factors for Parkinson\u2019s disease","volume":"48","author":"Gorell","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2011.05.001_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0404.2002.1o040.x","article-title":"Familial and environmental risk factors in Parkinson\u2019s disease: a case\u2013control study in northeast Italy","volume":"105","author":"Zorzon","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2011.05.001_bib6","series-title":"Parkinson\u2019s disease: diagnosis and clinical management","first-page":"407","article-title":"The impact of MPTP on Parkinson\u2019s disease research: past, present, and future","author":"Langston","year":"2008"},{"issue":"4","key":"10.1016\/j.ncl.2011.05.001_bib7","first-page":"435","article-title":"A\u00a0meta-analysis of Parkinson\u2019s disease and exposure to pesticides","volume":"21","author":"Priyadarshi","year":"2000","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ncl.2011.05.001_bib8","series-title":"Occupational medicine: state of the art reviews","first-page":"503","article-title":"Occupational and environmental causes of parkinsonism","author":"Tanner","year":"1992"},{"issue":"5","key":"10.1016\/j.ncl.2011.05.001_bib9","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson\u2019s disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorell","year":"1998","journal-title":"Neurology"},{"issue":"7113","key":"10.1016\/j.ncl.2011.05.001_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"33","key":"10.1016\/j.ncl.2011.05.001_bib11","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1523\/JNEUROSCI.1370-04.2004","article-title":"Stabilization of alpha-synuclein protein with aging and familial Parkinson\u2019s disease-linked A53T mutation","volume":"24","author":"Li","year":"2004","journal-title":"J\u00a0Neurosci"},{"issue":"3","key":"10.1016\/j.ncl.2011.05.001_bib12","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.ncl.2011.05.001_bib13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.nbd.2005.05.028","article-title":"Alpha-synuclein expression in the substantia nigra of MPTP-lesioned nonhuman primates","volume":"20","author":"Purisai","year":"2005","journal-title":"Neurobiol Dis"},{"issue":"Suppl 2","key":"10.1016\/j.ncl.2011.05.001_bib14","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.3233\/JAD-2010-100363","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"20","author":"Zhu","year":"2010","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"4587","key":"10.1016\/j.ncl.2011.05.001_bib15","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ncl.2011.05.001_bib16","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat Neurosci"},{"issue":"7","key":"10.1016\/j.ncl.2011.05.001_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0166-2236(03)00144-9","article-title":"The rotenone model of Parkinson\u2019s disease","volume":"26","author":"Perier","year":"2003","journal-title":"Trends Neurosci"},{"issue":"6","key":"10.1016\/j.ncl.2011.05.001_bib18","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson\u2019s disease","volume":"37","author":"Haas","year":"1995","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2011.05.001_bib19","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2011.05.001_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.10.061","article-title":"Complex I deficiency in Parkinson\u2019s disease frontal cortex","volume":"1189","author":"Parker","year":"2008","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.ncl.2011.05.001_bib21","first-page":"307","article-title":"Ultrastructural changes of the substantia nigra, ventral tegmental area and striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice","volume":"67","author":"Mizukawa","year":"1990","journal-title":"Res Commun Chem Pathol Pharmacol"},{"issue":"1","key":"10.1016\/j.ncl.2011.05.001_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0006-8993(90)91184-I","article-title":"Effects of MPTP on the fine structure of neurons in substantia nigra of dogs","volume":"512","author":"Rapisardi","year":"1990","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.ncl.2011.05.001_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00687790","article-title":"Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey","volume":"75","author":"Tanaka","year":"1988","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.ncl.2011.05.001_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.2000.7333","article-title":"Abnormal mitochondrial morphology in sporadic Parkinson\u2019s and Alzheimer\u2019s disease cybrid cell lines","volume":"162","author":"Trimmer","year":"2000","journal-title":"Exp Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2011.05.001_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0014-4886(03)00342-X","article-title":"Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP","volume":"186","author":"Song","year":"2004","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2011.05.001_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2353\/ajpath.2007.060524","article-title":"Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death","volume":"170","author":"Zhu","year":"2007","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.ncl.2011.05.001_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1177\/070674378903400916","article-title":"Four cases of progressive supranuclear palsy in patients exposed to organic solvents","volume":"34","author":"McCrank","year":"1989","journal-title":"Can J Psychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2011.05.001_bib28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/ana.410350516","article-title":"Parkinsonism induced by solvent abuse","volume":"35","author":"Uitti","year":"1994","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2011.05.001_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1006\/enfo.2000.0011","article-title":"A history of the production and use of carbon tetrachloride, tetrachloroethylene, trichloroethylene, and 1,1,1-trichloroethane in the United States: part 2-trichloroethylene and 1,1,1-trichloroethane","volume":"1","author":"Doherty","year":"2000","journal-title":"J Environmental Forensics"},{"key":"10.1016\/j.ncl.2011.05.001_bib30","series-title":"Kirk-Othmer Encyclopedia of Chemical Technology","author":"Kroschwitz","year":"1991"},{"key":"10.1016\/j.ncl.2011.05.001_bib31","series-title":"Toxicological profile for trichloroethylene","author":"Williams-Johnson","year":"1997"},{"key":"10.1016\/j.ncl.2011.05.001_bib32","series-title":"Occupational & environmental neurotoxicology","author":"Feldman","year":"1999"},{"key":"10.1016\/j.ncl.2011.05.001_bib33","series-title":"Assessing the human health risks of trichloroethylene: key scientific issues","author":"Trichloroethylene CoHHRo","year":"2006"},{"issue":"9","key":"10.1016\/j.ncl.2011.05.001_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ardp.19903230903","article-title":"Endogenous alkaloids in man, VII: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline\u2013a potential chloral-derived indol alkaloid in man","volume":"323","author":"Bringmann","year":"1990","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.ncl.2011.05.001_bib35","first-page":"245","article-title":"TaClo as a neurotoxic lead: improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain","volume":"46","author":"Bringmann","year":"1995","journal-title":"J\u00a0Neural Transm Suppl"},{"key":"10.1016\/j.ncl.2011.05.001_bib36","first-page":"235","article-title":"The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a new toxin for dopaminergic neurons","volume":"46","author":"Bringmann","year":"1995","journal-title":"J\u00a0Neural Transm Suppl"},{"key":"10.1016\/j.ncl.2011.05.001_bib37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-4615-0135-0_29","article-title":"The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson\u2019s disease","volume":"527","author":"Kochen","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ncl.2011.05.001_bib38","first-page":"255","article-title":"Studies of the potentially endogenous toxin TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) in neuronal and glial cell cultures","volume":"46","author":"Rausch","year":"1995","journal-title":"J\u00a0Neural Transm Suppl"},{"key":"10.1016\/j.ncl.2011.05.001_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1098-2299(199901)46:1<51::AID-DDR8>3.0.CO;2-B","article-title":"Effect of highly halogenated h-carbolines on dopaminergic cells in culture and on mitochondrial respiration","volume":"46","author":"Janetzky","year":"1999","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.ncl.2011.05.001_bib40","first-page":"83","article-title":"Neurotoxic effects on the dopaminergic system induced by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-\u03b2-carboline), a potential mammalian alkaloid: in\u00a0vivo and in\u00a0vitro studies","volume":"12","author":"Bringmann","year":"1996","journal-title":"Biog Amines"},{"key":"10.1016\/j.ncl.2011.05.001_bib41","first-page":"275","article-title":"Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives","volume":"46","author":"Grote","year":"1995","journal-title":"J\u00a0Neural Transm Suppl"},{"key":"10.1016\/j.ncl.2011.05.001_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01308-0","article-title":"Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline: a biologically relevant neurotoxin?","volume":"442","author":"Riederer","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.ncl.2011.05.001_bib43","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ejps.2006.03.009","article-title":"Synthesis of radiolabelled 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a neurotoxic chloral-derived mammalian alkaloid, and its biodistribution in rats","volume":"28","author":"Bringmann","year":"2006","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.ncl.2011.05.001_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0006-8993(90)90318-6","article-title":"Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products","volume":"509","author":"Drucker","year":"1990","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.ncl.2011.05.001_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-2952(96)00133-5","article-title":"Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"52","author":"McNaught","year":"1996","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.ncl.2011.05.001_bib46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1471-4159.2004.02710.x","article-title":"1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline-induced apoptosis in the human neuroblastoma cell line SK-N-SH","volume":"91","author":"Akundi","year":"2004","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.ncl.2011.05.001_bib47","first-page":"265","article-title":"1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline, a new inhibitor of complex I","volume":"46","author":"Janetzky","year":"1995","journal-title":"J\u00a0Neural Transm Suppl"},{"issue":"4","key":"10.1016\/j.ncl.2011.05.001_bib48","first-page":"659","article-title":"Trichloroethylene: long-lasting changes in the brain after rehabilitation","volume":"2","author":"Haglid","year":"1981","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.ncl.2011.05.001_bib49","first-page":"101","article-title":"Chronic effects of perchloroethylene and trichloroethylene on the gerbil brain amino acids and glutathione","volume":"7","author":"Briving","year":"1986","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ncl.2011.05.001_bib50","series-title":"West Hartford, CN (Health hazard evaluation\/toxicity determination report 72-84-31; US NTIS PB-229-627)","author":"Vandervort","year":"1973"},{"key":"10.1016\/j.ncl.2011.05.001_bib51","first-page":"545","volume":"vol. 20","year":"1979"},{"key":"10.1016\/j.ncl.2011.05.001_bib52","first-page":"75","volume":"vol. 63","year":"1979"},{"issue":"5","key":"10.1016\/j.ncl.2011.05.001_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1468-1331.1999.650609.x","article-title":"Trichloroethylene and parkinsonism: a human and experimental observation","volume":"6","author":"Guehl","year":"1999","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2011.05.001_bib54","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.21288","article-title":"Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity","volume":"63","author":"Gash","year":"2008","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2011.05.001_bib55","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1586\/ern.10.61","article-title":"Trichloroethylene and Parkinson\u2019s disease: dissolving the puzzle","volume":"10","author":"Goldman","year":"2010","journal-title":"Expert Rev Neurother"},{"issue":"3","key":"10.1016\/j.ncl.2011.05.001_bib56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1471-4159.2009.06497.x","article-title":"Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats","volume":"112","author":"Liu","year":"2010","journal-title":"J\u00a0Neurochem"},{"issue":"2","key":"10.1016\/j.ncl.2011.05.001_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson\u2019s disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"70","key":"10.1016\/j.ncl.2011.05.001_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/978-3-211-45295-0_23","article-title":"Nongenetic causes of Parkinson\u2019s disease","author":"Chade","year":"2006","journal-title":"J\u00a0Neural Transm Suppl"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861911000351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861911000351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T21:19:19Z","timestamp":1560374359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861911000351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0733861911000351"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2011.05.001","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}